McMichael Bryan J — SEC Form 4 filings
SEC reporting owner CIK 1944868. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-02.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-01-09 to 2026-06-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | Chief Financial Officer | 10 | — | — | 22 |
Form 4 filings — McMichael Bryan J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-02 | 4 | Coherus Oncology, Inc. (CHRS) | Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · +6 more | EDGAR |
| 2026-01-26 | 4 | Coherus Oncology, Inc. (CHRS) | Grant/award (A): 112,500 @ $0 · Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2026-01-22 | 4 | Coherus Oncology, Inc. (CHRS) | Tax withholding (F): 1,715 @ $1.55 | EDGAR |
| 2025-05-09 | 4 | Coherus BioSciences, Inc. (CHRS) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-01-22 | 4 | Coherus BioSciences, Inc. (CHRS) | Tax withholding (F): 1,711 @ $1.39 | EDGAR |
| 2025-01-10 | 4 | Coherus BioSciences, Inc. (CHRS) | Tax withholding (F): 1,711 @ $1.57 | EDGAR |
| 2025-01-07 | 4 | Coherus BioSciences, Inc. (CHRS) | Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2024-08-09 | 4 | Coherus BioSciences, Inc. (CHRS) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-01-23 | 4 | Coherus BioSciences, Inc. (CHRS) | Tax withholding (F): 1,707 @ $2.44 | EDGAR |
| 2024-01-09 | 4 | Coherus BioSciences, Inc. (CHRS) | Tax withholding (F): 1,707 @ $2.87 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1944868 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →